Last reviewed · How we verify

Cromoglicate — Competitive Intelligence Brief

Cromoglicate (Cromoglicate) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Respiratory.

discontinued Protein S100-P, G-protein coupled receptor 35, Taste receptor type 2 member 20 Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Cromoglicate (Cromoglicate) — LEO Pharma.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Cromoglicate TARGET Cromoglicate LEO Pharma discontinued Protein S100-P, G-protein coupled receptor 35, Taste receptor type 2 member 20
Cromoglycate Cromoglycate Vishwajit Nimgaonkar, MD PhD phase 3 Protein S100-P, G-protein coupled receptor 35, Taste receptor type 2 member 20

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cromoglicate — Competitive Intelligence Brief. https://druglandscape.com/ci/cromoglicate. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: